Improved Predictive Capacity of SARS‐CoV‐2 Seroconversion Using a Model Based on Torque Teno Virus Viral Load
Clinical Transplantation · 2026
DOI: 10.1111/ctr.70690 ↗At a glance
Beobachtungsstudie in Clinical Transplantation, 2026. Written by Eliana Hermida and 7 co-authors. Institution: Virology Unit, Centro De Educación Médica e Investigaciones Clínicas (CEMIC) University Hospital, Consejo Nacional De Investigaciones Científicas y T…. Major MEDLINE topics: Torque teno virus, Viral Load, SARS-CoV-2, COVID-19. 34 references. Funded by: CEMIC, Fundación "Norberto Quirno".
Abstract (original language)
Introduction
Kidney transplant patients (KTPs) exhibit markedly reduced seroconversion rates following SARS‐CoV‐2 vaccination due to chronic immunosuppression. Torque Teno virus (TTV) viral load has been proposed as a biomarker of immune competence.
Objectives
To determine the seroconversion rate to SARS‐CoV‐2 vaccination in KTPs and to develop a predictive model based on TTV viral load.
Methods
A prospective observational cohort study was conducted in adult KTPs with complete SARS‐CoV‐2 vaccination scheme. Anti‐Spike IgG antibodies were quantified. TTV viral load was quantified by qPCR. Logistic regression models were developed using TTV viral load alone and with patients’ variables (expanded model). Model performance was assessed using receiver operating characteristic analysis and internal validation.
Results
Seroconversion rate was 16.9% after complete vaccination, 21.9% after one booster and 55.5% after two boosters. TTV viral load alone showed modest predictive capacity for seroconversion (AUC = 0.634). The expanded model significantly improved prediction capacity (AUC = 0.814) with a NPV of 90.0%.
Conclusion
Pre‐vaccination TTV viral load alone is insufficient to predict seroconversion to SARS‐CoV‐2 vaccination in KTPs. The expanded model improved this predictive capacity when combined with clinical and vaccine related variables reflecting the multifactorial nature of immune competence. Integrative predictive approaches may help optimize vaccination strategies in immunocompromised populations.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Virology Unit, Centro De Educación Médica e Investigaciones Clínicas (CEMIC) University Hospital, Consejo Nacional De Investigaciones Científicas y Técnicas (CONICET), Buenos Aires, Argentina.
- Nephrology Department, CEMIC University Hospital, Buenos Aires, Argentina.
- Genetic Epidemiology Laboratory (CEMIC-CONICET), Buenos Aires, Argentina.
Funding
- CEMIC
- Fundación "Norberto Quirno"
Cite
APA
Hermida, E., Reyes, N. S., Jara, R., Boccia, N., Schiavone, M., Poletta, F. A., Laham, G., & Echavarria, M. (2026). Improved Predictive Capacity of SARS‐CoV‐2 Seroconversion Using a Model Based on Torque Teno Virus Viral Load. Clinical Transplantation. https://doi.org/10.1111/ctr.70690
Vancouver
Hermida E, Reyes NS, Jara R, Boccia N, Schiavone M, Poletta FA, et al. Improved Predictive Capacity of SARS‐CoV‐2 Seroconversion Using a Model Based on Torque Teno Virus Viral Load. Clinical Transplantation. 2026. doi:10.1111/ctr.70690
BibTeX
@article{Hermida2026,
author = {Hermida, Eliana and Reyes, Noelia Soledad and Jara, Raquel and Boccia, Natalia and Schiavone, Máximo and Poletta, Fernando Adrián and Laham, Gustavo and Echavarria, Marcela},
title = {Improved Predictive Capacity of SARS‐CoV‐2 Seroconversion Using a Model Based on Torque Teno Virus Viral Load},
journal = {Clinical Transplantation},
year = {2026},
doi = {10.1111/ctr.70690}
}
EUVIMED